Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy

Eye (Basingstoke)

Volumn 29, Issue 1, 2015, Pages 65-79

  Miller, N R ^a   Arnold, A C ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CORTICOSTEROID; ERYTHROPOIETIN; PHENYTOIN; PREDNISONE;

AFFERENT PUPILLARY DEFECT; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSESSMENT; DISEASE COURSE; EYE SURGERY; HUMAN; NONARTERITIC ANTERIOR ISCHAEMIC OPTIC NEUROPATHY; OPTIC DISK; OPTIC NERVE SHEATH FENESTRATION; OPTIC NEUROTOMY; PATHOGENESIS; PATHOPHYSIOLOGY; RETINA HEMORRHAGE; REVIEW; RISK FACTOR; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; ANIMAL; ARTERITIS; DISEASE MODEL; OPTIC NEUROPATHY, ISCHEMIC; PHYSIOLOGY;

ANIMALS; ARTERITIS; DISEASE MODELS, ANIMAL; HUMANS; OPTIC NEUROPATHY, ISCHEMIC; RISK FACTORS; VISUAL ACUITY;

EID: 84920585479     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.144     Document Type: Review

References (109)

1. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123: 103-107.
2. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy: population-based study in the State of Missouri and Los Angeles County, California. J Neuroophthalmol 1994; 14: 38-44.
3. Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985; 103: 1136-1142.
4. Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983; 96: 478-483.
5. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114: 1366-1374.
6. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 118: 766-780.
7. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999; 213: 76-96.
8. Swartz NG, Beck RW, Savino PJ, Sergott RC, Bosley TM, Lam BL et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol 1995; 15: 9-10.
9. Hayreh SS, Podhajsky P. Visual field defects in anterior ischemic optic neuropathy. Doc Ophthalmol Proc Ser 1979; 19: 53-71.
10. Traustason OI, Feldon SE, Leemaster JE, Weiner JM. Anterior ischemic optic neuropathy: classification of field defects by Octopus automated static perimetry. Graefes Arch Clin Exp Ophthalmol 1988; 226: 206-212.
11. Rader J, Feuer WJ, Anderson DR. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthalmol 1994; 117: 72-80.
12. Jonas JB, Gusek GC, Naumann GO. Anterior ischemic optic neuropathy: nonarteritic form in small and giant cell arteritis in normal-sized optic discs. Int Ophthalmol 1988; 12: 119-125.
13. Mansour AM, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. Am J Ophthalmol 1988; 106: 587-589.
14. Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984; 91: 1334-1337.
15. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 1987; 94: 1503-1508.
16. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993; 116: 759-764.
17. Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2007; 114: 1763-1772.
18. Arnold AC, Costa RMS, Dumitrascu OM. The spectrum of optic disc ischemia in patients younger than 50 years. Trans Am Ophthalmol Soc 2013; 111: 93-118.
19. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthalmol 2003; 23: 157-163.
20. Kaup M, Plange N, Arend KO, Remky A. Retrobulbar haemodynamics in non-arteritic ischaemic optic neuorpathy. Br J Ophthalmol 2006; 90: 1350-1353.
21. Knox DL, Duke JR. Slowly progressive ischemic optic neuropathy. A clinicopathologic case report. Trans Am Acad Ophthalmol Otolaryngol 1971; 75: 1065-1068.
22. Levin LA, Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 1996; 114: 488-491.
23. Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 117: 222-230.
24. Levin LA, Danesh-Meyer HV. Hypothesis. A venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2008; 126: 1582-1585.
25. Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2003; 110: 2031-2035.
26. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000; 98: 203-222.
27. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117: 603-624.
28. Landau K, Winterkorn JMS, Mailloux LU, Vetter W, Napolitano B. 24-Hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996; 114: 570-575.
29. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol 1997; 115: 1403-1407.
30. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999; 106: 739-742.
31. Lee MS, Grossman D, Arnold AC, Sloan FA. Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients. Ophthalmology 2011; 118: 959-963.
32. Talks SJ, Chong NH, Gibson JM, Dodson PM. Fibrinogen, cholesterol, and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye 1995; 9: 85-88.
33. Deramo VA, Sergott RC, Augsburger JJ, Foroozan R, Savino PJ, Leone A. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology 2003; 110: 1041-1045.
34. Chung SM, Gay CA, McCrary JA. Nonarteritic anterior ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994; 101: 779-782.
35. Mojon DS, Hedges 3rd TR, Ehrenberg B, Karam EZ, Goldblum D, Abou-Chebl A et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002; 120: 601-605.
36. Polombi K, Renard E, Levy P, Chiquet C, Ch Deschaux, Romanet JP et al. Non-arteritic anterior ischemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol 2006; 90: 879-882.
37. Li J, McGwin Jr G, Vaphiades MS, Owsley C. Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ). Br J Ophthalmol 2007; 91: 1524-1527.
38. Bilgin G, Koban Y, Arnold AC. Nonarteritic anterior ischemic optic neuropathy and obstructive sleep apnea. J Neuroophthalmol 2013; 33: 232-234.
39. Stein JD, Kim DS, Mundy KM, Talwar N, Nan B, Chervin RD et al. The association between glaucomatous and other causes of optic neuropathy and sleep apnea. Am J Ophthalmol 2011; 152: 989-998.
40. Kolb SD, Backhouse O. Obstructive sleep apnoea prevalence in non-arteritic anterior ischaemic optic neuropathy: a response. Br J Ophthalmol 2013; 97: 794.
41. Arda H, Birer S, Aksu M, Ismailogullari S, Karakucuk S, Mirza E et al. Obstructive sleep apnoea prevalence in non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2013; 97: 206-209.
42. Behbehani R, Mathews MK, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol 2005; 139: 518-521.
43. Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 2000; 107: 1588-1592.
44. Weger M, Stanger O, Deutschmann H, Simon M, Renner W, Schmut O et al. Hyperhomocysteinemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2001; 85: 803-806.
45. Biousse V, Kerrison JB, Newman NJ. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine? Br J Ophthalmol 2000; 84: 554.
46. Salomon O, Dardik R, Steinberg DM, Kurtz S, Rosenberg N, Moisseiev J et al. The role of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2000; 107: 1717-1720.
47. Salomon O, Rosenberg N, Steinberg DM, Huna-Baron R, Moisseiev J, Dardik R et al. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ib-alpha gene. Ophthalmology 2004; 111: 184-188.
48. Purvin V, King R, Kawasaki A, Yee R. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch Ophthalmol 2004; 122: 48-53.
49. Townes CD, Moran CT, Pfingst HA. Complications of cataract surgery. Trans Am Acad Ophthalmol 1951; 49: 91-107.
50. Reese AB, Carroll FD. Optic neuritis following cataract extraction. Am J Ophthalmol 1958; 45: 659-662.
51. Michaels DD, Zugsmith GS. Optic neuropathy following cataract extraction. Ann Ophthalmol 1973; 5: 303-306.
52. Carroll FD. Optic nerve complications of cataract extraction. Tr Am Acad Ophthalmol Otolaryngol 1973; 77: OP623-OP629.
53. McCulley TJ, Lam BL, Feuer WJ. Incidence of nonarteritic anterior ischemic optic neuropathy associated with cataract extraction. Ophthalmology 2001; 108: 1275-1278.
54. McCulley TJ, Lam BL, Feuer WJ. Nonarteritic anterior ischemic optic neuropathy and surgery of the anterior segment: temporal relationship analysis. Am J Ophthalmol 2003; 136: 1171-1172.
55. Lam BL, Jabaly-Habib H, Al-Sheikh N, Pezda M, Guirgis MF, Feuer WJ et al. Risk of non-arteritic anterior ischaemic optic neuropathy (NAION) after cataract extraction in the fellow eye of patients with prior unilateral NAION. Br J Ophthalmol 2007; 91: 585-587.
56. McDonald WI, Sanders MD. Migraine complicated by ischaemic papillopathy. Lancet 1971; 2: 521-523.
57. Katz B, Bamford CR. Migrainous ischemic optic neuropathy. Neurology 1985; 35: 112-114.
58. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alpha. Arch Ophthalmol 1995; 113: 1041-1044.
59. Gupta R, Singh S, Tang R, Blackwell TA, Schiffman JS. Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med 2002; 112: 683-684.
60. Vardizer Y, Linhart Y, Loewenstein A, Garzozi H, Mazawi N, Kesler A. Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy. J Neuroophthalmol 2003; 23: 256-259.
61. Pomeranz HD, Smith KH, Hart Jr WM, Egan RA. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109: 584-587.
62. Bollinger K, Lee MS. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol 2005; 123: 400-401.
63. Gittinger Jr JW, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol 1987; 105: 349-351.
64. Feiner LA, Younge BR, Kazmier FJ, Stricker BH, Fraunfelder FT. Optic neuropathy and amiodarone therapy. Mayo Clin Proc 1987; 62: 702-717.
65. Palimar P, Cota N. Bilateral anterior ischaemic optic neuropathy following amiodarone. Eye 1998; 12: 894-896.
66. Seemongal-Dass RR, Spencer SR. Bilateral optic neuropathy linked with amiodarone. Eye 1998; 12: 474-477.
67. Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol 1999; 127: 610-612.
68. Purvin V, Kawasaki A, Borruat FX. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 2006; 124: 696-701.
69. Mindel JS, Anderson J, Hellkamp A, Johnson G, Poole JE, Mark DB et al. Absence of bilateral vision loss from amiodarone: a randomized trial. Am Heart J 2007; 153: 837-842.
70. Murphy MA, Murphy JF. Amiodarone and optic neuropathy: the heart of the matter. J Neuroophthalmol 2005; 25: 232-236.
71. Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, Kerrigan DF et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 2000; 41: 3460-3466.
72. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 1994; 91: 1632-1636.
73. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997; 37: 3483-3493.
74. Levin LA, Clark JA, Johns LK. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest Ophthalmol Vis Sci 1996; 37: 2744-2749.
75. Vorwerk CK, Zurakowski D, McDermott LM, Mawrin C, Dreyer EB. Effects of axonal injury on ganglion cell survival and glutamate homeostasis. Brain Res Bull 2004; 62: 485-490.
76. Bernstein SL, Guo Y, Kelman SE, Flower RW, Johnson MA. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2003; 44: 4153-4162.
77. Goldenberg-Cohen N, Guo Y, Margolis F, Cohen Y, Miller NR, Bernstein SL. Oligodendrocyte dysfunction after induction of experimental anterior optic ischemia. Invest Ophthalmol Vis Sci 2005; 46: 2716-2725.
78. Pangratz-Fuehrer S, Kaur K, Ousman SS, Steinman L, Liao YJ. Functional rescue of experimental ischemic optic neuropathy with αB-crystallin. Eye 25: 809-817.
79. Chen CS, Johnson MA, Flower RA, Slater BJ, Miller NR, Bernstein SL. A primate model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2008; 49: 2985-2992.
80. Zhang C, Guo Y, Miller NR, Bernstein SL. Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION). Brain Res 2009; 1264: 67-75.
81. Salgado C, Vilson F, Miller NR, Bernstein SL. Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch Ophthalmol 2011; 129: 1583-1591.
82. Sawle GV, James CB, Ross Russell RW. The natural history of nonarteritic anterior ischaemic optic neuropathy. J Neurol Neurosurg Psychiatry 1990; 53: 830-833.
83. Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 1994; 14: 66-69.
84. Movsas T, Kelman SE, Elman MJ, Miller NR. The natural course of non-arteritic ischemic optic neuropathy. Invest Ophthalmol Vis Sci 1991; 32(Suppl): 951.
85. Ischemic Optic Neuropathy Decompression Trial Research Group. Twenty-four month update. Arch Ophthalmol 2000; 118: 793-798.
86. Borchert M, Lessell S. Progressive and recurrent nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1988; 106: 443-449.
87. Kline LB. Progression of visual defects in ischemic optic neuropathy. Am J Ophthalmol 1988; 106: 199-203.
88. Sergott RC, Cohen MS, Bosley TM, Savino PJ. Optic nerve sheath decompression may improve the progressive form of ischemic optic neuropathy. Arch Ophthalmol 1989; 107: 1743-1754.
89. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273: 625-632.
90. Scherer RW, Feldon SE, Levin L, Langenberg P, Katz J, Keyl PM et al. Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time. Ophthalmology 2008; 115: 1809-1817.
91. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2001; 132: 734-742.
92. Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1107-1121.
93. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123: 212-217.
94. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D et al. The fellow eye in NAION: report from the Ischemic Optic Neuropathy Decompression Trial follow-up study. Am J Ophthalmol 2002; 134: 317-328.
95. Keltner JL, Becker B, Gay AJ, Podos SM. Effect of diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc 1972; 70: 113-128.
96. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1029-1046.
97. Rebolleda G, Pérez-López M, Casas-Llera P, Muñoz-Negrete FJ. Treatment of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Graefes Arch Clin Exp Ophthalmol 2013; 251: 1031-1032.
98. Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol 2007; 27: 238-240.
99. Rootman D, Gill HS, Margolin EA. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial. Eye 2013; 27: 538-544.
100. Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG et al. Insight into 144 patients with ocular vascular events during VEGF antagonist injections. Clin Ophthalmol 2012; 6: 343-363.
101. Pankratova S, Kiryushko D, Sonn K, Soroka V, Køhler LB, Rathje M et al. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain 2010; 133: 2281-2294.
102. Modarres M, Falavarjani KG, Nazari H, Sanjari MS, Aghamohammadi F, Homaii M et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2011; 95: 992-995.
103. Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1996; 122: 535-541.
104. Spoor TC, Wilkinson MJ, Ramocki JM. Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy. Am J Ophthalmol 1991; 111: 724-728.
105. Kelman SE, Elman MJ. Optic nerve sheath decompression for nonarteritic anterior ischemic optic neuropathy improves multiple visual function measurements. Arch Ophthalmol 1991; 109: 667-671.
106. Soheilian M, Koochek A, Yazdani S, Peyman GA. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina 2003; 23: 692-697.
107. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 1997; 17: 250-253.
108. Salomon O, Huna-Baron R, Steinberg DM, Kurtz S, Seligsohn U. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye 1999; 13: 357-359.
109. Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye 2000; 14: 118.